Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options
- 17 December 2020
- journal article
- research article
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 20 (2), e139-e149
- https://doi.org/10.1016/j.clcc.2020.12.001
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal CanalAmerican Journal of Clinical Oncology, 2017
- Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine CarcinomaMedicine, 2015
- Large Cell Neuroendocrine Carcinoma of the Rectum Presenting with Extensive Metastatic DiseaseCase Reports in Oncological Medicine, 2014
- Long term outcomes of neuroendocrine carcinomas (high-grade neuroendocrine tumors) of the colon, rectum, and anal canalJournal of Visceral Surgery, 2014
- The Management of Extrapulmonary Poorly Differentiated (High-Grade) Neuroendocrine CarcinomasSeminars in Oncology, 2013
- Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC studyAnnals of Oncology, 2012
- The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine CarcinomasPancreas, 2010
- An Unusual Case of Small Cell Carcinoma of the Anal CanalAmerican Journal of Clinical Oncology, 2009
- T1 Neuroendocrine Carcinoma of Anal Canal after Transanal Resection for Intramucosal AdenocarcinomaJapanese Journal of Clinical Oncology, 2006
- The effectiveness of chemotherapy with cisplatin and 5-fluorouracil for recurrent small cell neuroendocrine carcinoma of the rectum: Report of a caseSurgery Today, 1999